Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig L Slingluff

Showing results (131-140 of 226) with videos related to

Pageof 23
Sort By:
Immunology Letters|December 23, 2003
Identification of a shared epitope recognized by melanoma-specific, HLA-A3-restricted cytotoxic T lymphocytesKevin T Hogan, Michael A Coppola, Christine L Gatlin, et al.
Cancer Research|November 3, 2004
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III diseaseIrene M Mullins, Craig L Slingluff, Jae K Lee, et al.
Journal of Hematology & Oncology|October 7, 2017
Erratum to: Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile testEddy C Hsueh, James R DeBloom, Jonathan Lee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Competition among peptides in melanoma vaccines for binding to MHC moleculesLee W Thompson, Courtney F Garbee, Sarah Hibbitts, et al.
Plos One|September 26, 2015
Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant MelanomaBrian J Capaldo, Devin Roller, Mark J Axelrod, et al.
Annals of Surgical Oncology|January 16, 2026
Patterns and Predictors of Sentinel Lymph Node Biopsy Utilization in High- and Low-Risk Thin MelanomasMackenzie M Mayhew, Emily G Tocco, Margaret G Mercante, et al.
Cancer Immunology, Immunotherapy : CII|May 13, 2005
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patientsWilliam Chad Cragun, Galina V Yamshchikov, Eric A Bissonette, et al.
Journal of Hematology & Oncology|August 31, 2017
Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile testEddy C Hsueh, James R DeBloom, Jonathan Lee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptidesRebecca C Harris, Kimberly A Chianese-Bullock, Gina R Petroni, et al.
Annals of Surgical Oncology|November 2, 2019
Correction to: Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal MetastasisMinyoung Kwak, Yun Song, Phyllis A Gimotty, et al.
Pageof 23

Showing results (131-140 of 226) with videos related to

Sort By:
Pageof 23
Immunology Letters|December 23, 2003
Identification of a shared epitope recognized by melanoma-specific, HLA-A3-restricted cytotoxic T lymphocytesKevin T Hogan, Michael A Coppola, Christine L Gatlin, et al.
Cancer Research|November 3, 2004
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III diseaseIrene M Mullins, Craig L Slingluff, Jae K Lee, et al.
Journal of Hematology & Oncology|October 7, 2017
Erratum to: Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile testEddy C Hsueh, James R DeBloom, Jonathan Lee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Competition among peptides in melanoma vaccines for binding to MHC moleculesLee W Thompson, Courtney F Garbee, Sarah Hibbitts, et al.
Plos One|September 26, 2015
Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant MelanomaBrian J Capaldo, Devin Roller, Mark J Axelrod, et al.
Annals of Surgical Oncology|January 16, 2026
Patterns and Predictors of Sentinel Lymph Node Biopsy Utilization in High- and Low-Risk Thin MelanomasMackenzie M Mayhew, Emily G Tocco, Margaret G Mercante, et al.
Cancer Immunology, Immunotherapy : CII|May 13, 2005
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patientsWilliam Chad Cragun, Galina V Yamshchikov, Eric A Bissonette, et al.
Journal of Hematology & Oncology|August 31, 2017
Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile testEddy C Hsueh, James R DeBloom, Jonathan Lee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptidesRebecca C Harris, Kimberly A Chianese-Bullock, Gina R Petroni, et al.
Annals of Surgical Oncology|November 2, 2019
Correction to: Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal MetastasisMinyoung Kwak, Yun Song, Phyllis A Gimotty, et al.
Pageof 23